In patients with AD and amnestic mild cognitive impairment (aMCI), elevated serum levels of zonulin—a regulator of intestinal tight junctions—indicate increased gut permeability, with higher levels predicting progression from aMCI to AD (Boschetti et al., 2023). This evidence concerns the gene HP and Alzheimer disease.